List of Cayman Chemical Company patents

Patents where

Current Assignee

Name

Cayman Chemical Company

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7358275 Internal 1,15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertension	Patent 7358275 was granted and assigned to Cayman Chemical Company on April, 2008 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	7358275	April 15, 2008
‌ US Patent 9688627 Lactam compounds as EP	Patent 9688627 was granted and assigned to Cayman Chemical Company on June, 2017 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	9688627	June 27, 2017
‌ US Patent 11066361 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions	Patent 11066361 was granted and assigned to Cayman Chemical Company on July, 2021 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	11066361	July 20, 2021
‌ US Patent 9676712 Lactam compounds as EP	Patent 9676712 was granted and assigned to Cayman Chemical Company on June, 2017 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	9676712	June 13, 2017
‌ US Patent 9914725 Methods of synthesizing a difluorolactam analog	Patent 9914725 was granted and assigned to Cayman Chemical Company on March, 2018 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	9914725	March 13, 2018
‌ US Patent 11345690 Methods of synthesizing a difluorolactam analog	Patent 11345690 was granted and assigned to Cayman Chemical Company on May, 2022 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	11345690	May 31, 2022
‌ US Patent 10450257 Methods of synthesizing a prostacyclin analog	Patent 10450257 was granted and assigned to Cayman Chemical Company on October, 2019 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	10450257	October 22, 2019
‌ US Patent 9908834 Methods of synthesizing a prostacyclin analog	Patent 9908834 was granted and assigned to Cayman Chemical Company on March, 2018 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	9908834	March 6, 2018
‌ US Patent 8063240 Prostaglandin E1 and E2 analogs for the treatment of various medical conditions	Patent 8063240 was granted and assigned to Cayman Chemical Company on November, 2011 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	8063240	November 22, 2011
‌ US Patent 10155716 Amine salts of a prostacyclin analog	Patent 10155716 was granted and assigned to Cayman Chemical Company on December, 2018 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	10155716	December 18, 2018
‌ US Patent 9180116 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions	Patent 9180116 was granted and assigned to Cayman Chemical Company on November, 2015 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	9180116	November 10, 2015
‌ US Patent 8440417 Method for assaying compounds or agents for ability to displace potent ligands of hematopoietic prostaglandin D synthase	Patent 8440417 was granted and assigned to Cayman Chemical Company on May, 2013 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	8440417	May 14, 2013
‌ US Patent 9487478 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions	Patent 9487478 was granted and assigned to Cayman Chemical Company on November, 2016 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	9487478	November 8, 2016
‌ US Patent 7674921 Internal 1,15-lactones of fluprostenol and related prostaglandin F	Patent 7674921 was granted and assigned to Cayman Chemical Company on March, 2010 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	7674921	March 9, 2010
‌ US Patent 9126973 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D	Patent 9126973 was granted and assigned to Cayman Chemical Company on September, 2015 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	9126973	September 8, 2015
‌ US Patent 9708287 Chiral compounds, compositions, products and methods employing same	Patent 9708287 was granted and assigned to Cayman Chemical Company on July, 2017 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	9708287	July 18, 2017
‌ US Patent 9890104 Amine salts of a prostacyclin analog	Patent 9890104 was granted and assigned to Cayman Chemical Company on February, 2018 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	9890104	February 13, 2018
‌ US Patent 8901319 Process for the preparation of F-series prostaglandins	Patent 8901319 was granted and assigned to Cayman Chemical Company on December, 2014 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	8901319	December 2, 2014
‌ US Patent 7585889 Internal 1,15-lactones of fluprostenol and related prostaglandin F	Patent 7585889 was granted and assigned to Cayman Chemical Company on September, 2009 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	7585889	September 8, 2009
‌ US Patent 8680327 Methods for manufacturing tetranor-prostaglandin D, J, E, A and F metabolites	Patent 8680327 was granted and assigned to Cayman Chemical Company on March, 2014 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	8680327	March 25, 2014
‌ US Patent 10556862 Difluorolactam compounds as EP	Patent 10556862 was granted and assigned to Cayman Chemical Company on February, 2020 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	10556862	February 11, 2020
‌ US Patent 8450326 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases	Patent 8450326 was granted and assigned to Cayman Chemical Company on May, 2013 by the United States Patent and Trademark Office.		Cayman Chemical Company	United States Patent and Trademark Office	8450326	May 28, 2013
‌ US Patent 8536185 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseases			Cayman Chemical Company	United States Patent and Trademark Office	8536185	September 17, 2013
‌ US Patent 11884624 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditions	Patent 11884624 was granted and assigned to Cayman Chemical Company on January, 2024 by the United States Patent and Trademark Office.	Cayman Chemical Company	Cayman Chemical Company	United States Patent and Trademark Office	11884624	January 30, 2024

24 results

0 selected

24 results

0 selected